For a hardware founder burning $200,000 a month on R&D payroll, the SR&ED tax credit is not a luxury. It is often the difference between 18 months of runway and 12. That calculation is now in flux, and Vancouver's deep-tech community is adjusting its strategy.
The federal government's consultation proposals for the Scientific Research and Experimental Development program could reduce the enhanced refundable credit rate available to Canadian-Controlled Private Corporations (CCPCs) and narrow the pool of eligible expenditures. For founders who have built financial models around SR&ED as a predictable, non-dilutive cash source, the timing is challenging: many are mid-cycle on R&D programs that cannot be paused.
The numbers at stake
The SR&ED program delivers approximately $4 billion annually to Canadian businesses. BC firms claimed roughly $480 million in the most recent reporting year, reflecting the province's concentration of tech, life sciences, and advanced manufacturing.
Under current rules, CCPCs receive a 35% enhanced refundable credit on the first $3 million of eligible expenditures. The proposed reform would reduce that threshold. For a biotech startup spending $2.5 million annually on qualifying R&D, a reduction in the eligible base could translate to $100,000 or more in lost non-dilutive capital.
Hardware and biotech startups have historically recovered between 25% and 40% of annual R&D payroll through SR&ED claims. This recovery rate helps make Vancouver a viable hub for capital-intensive deep-tech companies.
The competitive context
Vancouver's deep-tech founders are already navigating a seed-stage capital drought. The Council of Canadian Innovators has raised concerns about the proposed changes, arguing that reducing SR&ED's generosity risks accelerating the migration of deep-tech talent and IP to jurisdictions with more aggressive R&D incentives.
The BC Tech Association has been surveying members on R&D financing. Early signals suggest that uncertainty is affecting planning, with founders building conservative financial models to account for a range of potential outcomes.
Operational responses
The practical response from Vancouver's deep-tech community is falling into three categories. First, founders are stress-testing runway assumptions. A quantum computing startup that modelled 20 months of runway based on current SR&ED recoveries may now be looking at 14 to 16 months under a reduced-rate scenario.
Second, SR&ED advisory firms are reporting increased demand for scenario planning. KPMG and MNP have noted that the proposed narrowing of eligible expenditures could affect claims more significantly than the headline rate change.
Third, some founders are accelerating SR&ED claims for the current fiscal year to lock in existing rates before any amendments take effect.
The bigger picture
SR&ED reform is not inherently negative. There are legitimate critiques regarding the program's administration, and simplification could reduce the compliance burden on small teams. However, the timing and specifics matter. Reducing the enhanced rate or narrowing eligible expenditures without offsetting mechanisms effectively raises the cost of R&D in Canada.
The Finance Canada consultation process remains open. Founders and ecosystem organizations have the opportunity to provide feedback before legislative language is finalized. For those rebuilding financial models, the most prudent approach is to treat SR&ED recoveries as a range rather than a fixed input until the policy is settled.
